{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:40:44Z","timestamp":1770352844526,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10384-020-00774-9","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:05:50Z","timestamp":1602043550000},"page":"568-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases"],"prefix":"10.1007","volume":"64","author":[{"given":"Dai","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Uchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"774_CR1","doi-asserted-by":"crossref","first-page":"18205","DOI":"10.1038\/s41598-019-54841-4","volume":"9","author":"D Miyazaki","year":"2019","unstructured":"Miyazaki D, Fukagawa K, Fukushima A, Fujishima H, Uchio E, Ebihara N, et al. Air pollution significantly associated with severe ocular allergic inflammatory diseases. Sci Rep. 2019;9:18205.","journal-title":"Sci Rep"},{"key":"774_CR2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, Rama P, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology. 2000;107:1157\u201363.","journal-title":"Ophthalmology"},{"issue":"988\u201392","key":"774_CR3","first-page":"e5","volume":"115","author":"D Miyazaki","year":"2008","unstructured":"Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology. 2008;115(988\u201392):e5.","journal-title":"Ophthalmology"},{"key":"774_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","volume":"25","author":"N Ebihara","year":"2009","unstructured":"Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2009;25:365\u201372.","journal-title":"J Ocul Pharmacol Ther."},{"key":"774_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","volume":"26","author":"Y Ohashi","year":"2010","unstructured":"Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y, et al. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010;26:165\u201374.","journal-title":"J Ocul Pharmacol Ther."},{"key":"774_CR6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","volume":"8","author":"A Fukushima","year":"2014","unstructured":"Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Kumagai N, et al. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol. 2014;8:1023\u20137.","journal-title":"Br J Ophthalmol"},{"key":"774_CR7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/02713683.2019.1600197","volume":"44","author":"J Shoji","year":"2019","unstructured":"Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, et al. Topical tacrolimus for chronic allergic conjunctival disease with and without atopic dermatitis. Curr Eye Res. 2019;44:796\u2013805.","journal-title":"Curr Eye Res"},{"key":"774_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0420.1999.tb01164.x","volume":"77","author":"M Calonge","year":"1999","unstructured":"Calonge M. Classification of ocular atopic\/allergic disorders and conditions: an unsolved problem. Acta Ophthalmol Scand Suppl. 1999;77:10\u20133.","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"774_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09286580802573177","volume":"16","author":"A Lambiase","year":"2009","unstructured":"Lambiase A, Minchiotti S, Leonardi A, Secchi AG, Rolando M, Calabria G, et al. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population. Ophthalmic Epidemiol. 2009;16:38\u201341.","journal-title":"Ophthalmic Epidemiol"},{"key":"774_CR10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.alit.2020.03.005","volume":"69","author":"D Miyazaki","year":"2020","unstructured":"Miyazaki D, Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, et al. Japanese guidelines for allergic conjunctival diseases 2020. Allergol Int. 2020;69:346\u201355.","journal-title":"Allergol Int"},{"key":"774_CR11","first-page":"863","volume":"61","author":"KJ Myers","year":"1990","unstructured":"Myers KJ, Lalle P, Litwak A, Campbell S, Ballinger R, Grolman B. XPERT NCT\u2013a clinical evaluation. J Am Optom Assoc. 1990;61:863\u20139.","journal-title":"J Am Optom Assoc"},{"key":"774_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0039-6257(80)90042-9","volume":"24","author":"MB Shields","year":"1980","unstructured":"Shields MB. The non-contact tonometer. Its value and limitations. Surv Ophthalmol. 1980;24:211\u20139.","journal-title":"Surv Ophthalmol"},{"key":"774_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. Arch Ophthalmol. 1963;70:492\u20139.","journal-title":"Arch Ophthalmol"},{"key":"774_CR14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archopht.1963.00960050502012","volume":"70","author":"B Becker","year":"1963","unstructured":"Becker B. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500\u20137.","journal-title":"Arch Ophthalmol"},{"key":"774_CR15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.1963.03060110088027","volume":"185","author":"B Becker","year":"1963","unstructured":"Becker B, Mills DW. Elevated intraocular pressure following corticosteroid eye drops. JAMA. 1963;185:884\u20136.","journal-title":"JAMA"},{"key":"774_CR16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9394(64)92500-0","volume":"57","author":"B Becker","year":"1964","unstructured":"Becker B, Hahn KA. Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol. 1964;57:543\u201351.","journal-title":"Am J Ophthalmol"},{"key":"774_CR17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archopht.1964.00970020771005","volume":"72","author":"B Becker","year":"1964","unstructured":"Becker B. The effect of topical corticosteroids in secondary glaucomas. Arch Ophthalmol. 1964;72:769\u201371.","journal-title":"Arch Ophthalmol"},{"key":"774_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archopht.1964.00970020189009","volume":"72","author":"J Nicholas","year":"1964","unstructured":"Nicholas J. Topical corticosteroids and aqueous humor dynamics. Arch Ophthalmol. 1964;72:189\u201397.","journal-title":"Arch Ophthalmol"},{"key":"774_CR19","first-page":"187","volume":"4","author":"MF Armaly","year":"1965","unstructured":"Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol. 1965;4:187\u201397.","journal-title":"Invest Ophthalmol"},{"key":"774_CR20","first-page":"198","volume":"4","author":"B Becker","year":"1965","unstructured":"Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol. 1965;4:198\u2013205.","journal-title":"Invest Ophthalmol"},{"key":"774_CR21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0002-9394(66)91908-8","volume":"62","author":"J Francois","year":"1966","unstructured":"Francois J, Heintz-de Bree CH, Tripathi RC. The cortisone test and the heredity of primary open-angle glaucoma. Am J Ophthalmol. 1966;62:844\u201352.","journal-title":"Am J Ophthalmol"},{"key":"774_CR22","first-page":"126","volume":"6","author":"N Ballin","year":"1967","unstructured":"Ballin N, Becker B. Provocative testing for primary open-angle glaucoma in \u201csenior citizens\u201d. Invest Ophthalmol. 1967;6:126\u201331.","journal-title":"Invest Ophthalmol"},{"key":"774_CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archopht.1967.00980020595005","volume":"77","author":"R Levene","year":"1967","unstructured":"Levene R, Wigdor A, Edelstein A, Baum J. Topical corticosteroid in normal patients and glaucoma suspects. Arch Ophthalmol. 1967;77:593\u20137.","journal-title":"Arch Ophthalmol"},{"key":"774_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archopht.1973.01000050283006","volume":"90","author":"JT Schwartz","year":"1973","unstructured":"Schwartz JT, Reuling FH, Feinleib M, Garrison RJ, Collie DJ. Twin study on ocular pressure following topically applied dexamethasone. II. Inheritance of variation in pressure response. Arch Ophthalmol. 1973;90:281\u20136.","journal-title":"Arch Ophthalmol"},{"key":"774_CR25","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1001\/archopht.1979.01020020457010","volume":"97","author":"RH Stewart","year":"1979","unstructured":"Stewart RH, Kimbrough RL. Intraocular pressure response to topically administered fluorometholone. Arch Ophthalmol. 1979;97:2139\u201340.","journal-title":"Arch Ophthalmol"},{"key":"774_CR26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9394(14)76256-7","volume":"112","author":"M Ohji","year":"1991","unstructured":"Ohji M, Kinoshita S, Ohmi E, Kuwayama Y. Marked intraocular pressure response to instillation of corticosteroids in children. Am J Ophthalmol. 1991;112:450\u20134.","journal-title":"Am J Ophthalmol"},{"key":"774_CR27","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0161-6420(97)30052-9","volume":"104","author":"AK Kwok","year":"1997","unstructured":"Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ocular-hypertensive response to topical steroids in children. Ophthalmology. 1997;104:2112\u20136.","journal-title":"Ophthalmology"},{"key":"774_CR28","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0161-6420(00)00357-2","volume":"107","author":"JS Ng","year":"2000","unstructured":"Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, et al. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon. Ophthalmology. 2000;107:2097\u2013100.","journal-title":"Ophthalmology"},{"key":"774_CR29","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/archopht.121.12.1716","volume":"121","author":"DS Fan","year":"2003","unstructured":"Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, et al. Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Arch Ophthalmol. 2003;121:1716\u201321.","journal-title":"Arch Ophthalmol"},{"key":"774_CR30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1442-9071.2005.01022.x","volume":"33","author":"DS Lam","year":"2005","unstructured":"Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin Exp Ophthalmol. 2005;33:252\u20138.","journal-title":"Clin Exp Ophthalmol"},{"key":"774_CR31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/OPTH.S32936","volume":"6","author":"M Ang","year":"2012","unstructured":"Ang M, Ti SE, Loh R, Farzavandi S, Zhang R, Tan D, et al. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol. 2012;6:1253\u20138.","journal-title":"Clin Ophthalmol"},{"issue":"Suppl 2","key":"774_CR32","first-page":"S151","volume":"98","author":"M Makornwattana","year":"2015","unstructured":"Makornwattana M, Suphachearaphan W. Incidence of steroid induced-ocular hypertension in postoperative pterygium excision. J Med Assoc Thai. 2015;98(Suppl 2):S151\u2013S157157.","journal-title":"J Med Assoc Thai"},{"key":"774_CR33","first-page":"14","volume":"18","author":"CHY Lai","year":"2014","unstructured":"Lai CHY, Dorothy SPF, Jonathan CHC. Corticosteroid-induced glaucoma in children. HKJ Ophthalmol. 2014;18:14\u20139.","journal-title":"HKJ Ophthalmol"},{"key":"774_CR34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000328630","volume":"47","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res. 2012;47:66\u201380.","journal-title":"Ophthalmic Res"},{"key":"774_CR35","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0161-6420(01)00781-3","volume":"108","author":"DS Fan","year":"2001","unstructured":"Fan DS, Ng JS, Lam DS. A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Ophthalmology. 2001;108:1973\u20137.","journal-title":"Ophthalmology"},{"key":"774_CR36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/bjo.64.6.430","volume":"64","author":"BZ Biedner","year":"1980","unstructured":"Biedner BZ, David R, Grudsky A, Sachs U. Intraocular pressure response to corticosteroids in children. Br J Ophthalmol. 1980;64:430\u20131.","journal-title":"Br J Ophthalmol"},{"key":"774_CR37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1167\/iovs.12-11067","volume":"54","author":"SK Bhattacharya","year":"2013","unstructured":"Bhattacharya SK, Lee RK, Grus FH. Molecular biomarkers in glaucoma. Invest Ophthalmol Vis Sci. 2013;54:121\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"774_CR38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.2009.158261","volume":"94","author":"S Sohn","year":"2010","unstructured":"Sohn S, Hur W, Choi YR, Chung YS, Ki CS, Kee C. Little evidence for association of the glaucoma gene MYOC with open-angle glaucoma. Br J Ophthalmol. 2010;94:639\u201342.","journal-title":"Br J Ophthalmol"},{"key":"774_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2014.11.009","volume":"130","author":"JA Faralli","year":"2015","unstructured":"Faralli JA, Clark RW, Filla MS, Peters DM. NFATc1 activity regulates the expression of myocilin induced by dexamethasone. Exp Eye Res. 2015;130:9\u201316.","journal-title":"Exp Eye Res"},{"key":"774_CR40","first-page":"2001","volume":"18","author":"KE Bollinger","year":"2012","unstructured":"Bollinger KE, Crabb JS, Yuan X, Putliwala T, Clark AF, Crabb JW. Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cells. Mol Vis. 2012;18:2001\u201311.","journal-title":"Mol Vis"},{"key":"774_CR41","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1172\/JCI69774","volume":"124","author":"GS Zode","year":"2014","unstructured":"Zode GS, Sharma AB, Lin X, Searby CC, Bugge K, Kim GH, et al. Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma. J Clin Invest. 2014;124:1956\u201365.","journal-title":"J Clin Invest"},{"key":"774_CR42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/acs.jproteome.6b00638","volume":"16","author":"D Kim","year":"2017","unstructured":"Kim D, Hwang HY, Kim JY, Lee JY, Yoo JS, Marko-Varga G, et al. FK506, an immunosuppressive drug, induces autophagy by binding to the V-ATPase catalytic subunit a in neuronal cells. J Proteome Res. 2017;16:55\u201364.","journal-title":"J Proteome Res"},{"key":"774_CR43","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1074\/jbc.275.18.13571","volume":"275","author":"LJ De Windt","year":"2000","unstructured":"De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J Biol Chem. 2000;275:13571\u20139.","journal-title":"J Biol Chem."},{"key":"774_CR44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jcb.23419","volume":"113","author":"CC Huang","year":"2012","unstructured":"Huang CC, Ko ML, Vernikovskaya DI, Ko GY. Calcineurin serves in the circadian output pathway to regulate the daily rhythm of L-type voltage-gated calcium channels in the retina. J Cell Biochem. 2012;113:911\u201322.","journal-title":"J Cell Biochem."},{"key":"774_CR45","doi-asserted-by":"crossref","first-page":"22923","DOI":"10.1074\/jbc.274.33.22923","volume":"274","author":"SA Trushin","year":"1999","unstructured":"Trushin SA, Pennington KN, Algeciras-Schimnich A, Paya CV. Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytes. J Biol Chem. 1999;274:22923\u201331.","journal-title":"J Biol Chem."},{"key":"774_CR46","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1038\/s41598-018-32725-3","volume":"8","author":"I Chono","year":"2018","unstructured":"Chono I, Miyazaki D, Miyake H, Komatsu N, Ehara F, Nagase D, et al. High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep. 2018;8:14533.","journal-title":"Sci Rep."},{"key":"774_CR47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2015.3234","volume":"48","author":"X Long","year":"2016","unstructured":"Long X, Ye Y, Zhang L, Liu P, Yu W, Wei F, et al. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). Int J Oncol. 2016;48:5\u201312.","journal-title":"Int J Oncol."},{"key":"774_CR48","doi-asserted-by":"crossref","first-page":"26357","DOI":"10.1074\/jbc.M112.446138","volume":"288","author":"HS Kwon","year":"2013","unstructured":"Kwon HS, Johnson TV, Joe MK, Abu-Asab M, Zhang J, Chan CC, et al. Myocilin mediates myelination in the peripheral nervous system through ErbB2\/3 signaling. J Biol Chem. 2013;288:26357\u201371.","journal-title":"J Biol Chem."},{"key":"774_CR49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ophtha.2016.11.002","volume":"124","author":"D Miyazaki","year":"2017","unstructured":"Miyazaki D, Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, et al. Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases. Ophthalmology. 2017;124:287\u201394.","journal-title":"Ophthalmology"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-020-00774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-020-00774-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-020-00774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:36:51Z","timestamp":1603931811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-020-00774-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1007\/s10384-020-00774-9","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D. Miyazaki, Lecture fee (Santen, Senju, Alcon); Y. Inoue, Grant, Lecture fee, Consultant fee (Senju), Grant (Santen, Alcon); J. Shoji, Lecture fee (Santen, Senju, Alcon); D. Shimizu, None; A. Fukushima, Grant, Lecture fee (Santen, Senju, Alcon, Mitsubishi Tanabe, Pfizer, Otsuka), Lecture fee (Eisai, AbbVie, Kowa, Kyowa Kirin); K. Namba, Financial support, Lecture fee (Mitsubishi Tanabe, Eisai, AbbVie), Financial support (EP-CRSU), Lecture fee (HOYA, Santen, Senju, Alcon, Novartis, Pfizer, Kowa, AstraZeneca, Chugai); Y. Ohashi, None; N. Ebihara, None; E. Uchio, None; S. Okamoto, None; E. Takamura, None; H. Fujishima, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}